[Diabetes mellitus and cerebrovascular disorders].
Udaka
Fukashi
F
Department of Neurology, Sumitomo Hospital.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications; D001777:Blood Coagulation; D002544:Cerebral Infarction / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D010975:Platelet Aggregation Inhibitors